Literature DB >> 21573951

APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1.

Eva Heger1, Alexander Thielen, Ramona Gilles, Martin Obermeier, Thomas Lengauer, Rolf Kaiser, Susanna Trapp.   

Abstract

Human immunodeficiency virus-1 tropism highly correlates with the amino acid (aa) composition of the third hypervariable region (V3) of gp120. A shift towards more positively charged aa is seen when binding to CXCR4 compared with CCR5 (X4 vs. R5 strains), especially positions 11 and 25 (11/25-rule) predicting X4 viruses in the presence of positively charged residues. At nucleotide levels, negatively or uncharged aa, e.g., aspartic and glutamic acid and glycine, which are encoded by the triplets GAN (guanine-adenosine-any nucleotide) or GGN are found more often in R5 strains. Positively charged aa such as arginine and lysine encoded by AAR or AGR (CGN) (R means A or G) are seen more frequently in X4 strains suggesting our hypothesis that a switch from R5 to X4 strains occurs via a G-to-A mutation. 1527 V3 sequences from three independent data sets of X4 and R5 strains were analysed with respect to their triplet composition. A higher number of G-containing triplets was found in R5 viruses, whereas X4 strains displayed a higher content of A-comprising triplets. These findings also support our hypothesis that G-to-A mutations are leading to the co-receptor switch from R5 to X4 strains. Causative agents for G-to-A mutations are the deaminases APOBEC3F and APOBEC3G. We therefore hypothesize that these proteins are one driving force facilitating the appearance of X4 variants. G-to-A mutations can lead to a switch from negatively to positively charged aa and a respective alteration of the net charge of gp120 resulting in a change of co-receptor usage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21573951     DOI: 10.1007/s00430-011-0199-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  43 in total

1.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.

Authors:  J J De Jong; A De Ronde; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.

Authors:  Craig Pace; Jean Keller; David Nolan; Ian James; Silvana Gaudieri; Corey Moore; Simon Mallal
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

4.  Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.

Authors:  Jeffrey Pido-Lopez; Trevor Whittall; Yufei Wang; Lesley A Bergmeier; Kaboutar Babaahmady; Mahavir Singh; Thomas Lehner
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

5.  Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.

Authors:  Shu-Ye Zhang; Zheng Zhang; Jun-Liang Fu; Fu-Biao Kang; Xiang-Sheng Xu; Wei-Min Nie; Chun-Bao Zhou; Min Zhao; Fu-Sheng Wang
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

6.  Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.

Authors:  G Herbein; U Mahlknecht; F Batliwalla; P Gregersen; T Pappas; J Butler; W A O'Brien; E Verdin
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

7.  Cytidine deamination induced HIV-1 drug resistance.

Authors:  Lubbertus C F Mulder; Ariana Harari; Viviana Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

8.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

9.  Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.

Authors:  Jason F Kreisberg; Wes Yonemoto; Warner C Greene
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

10.  Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3).

Authors:  Satish K Pillai; Joseph K Wong; Jason D Barbour
Journal:  Retrovirology       Date:  2008-03-13       Impact factor: 4.602

View more
  8 in total

1.  Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Liliana Elena Weimer; Maria Franca Pirillo; Anna Volpe; Alessandra Mercuri; Albertina Cavalli; Vincenzo Fragola; Laura Monno; Anna Degli Antoni; Nicoletta Ladisa; Daniela Francisci; Raffaella Bucciardini; Marco Floridia
Journal:  J Antimicrob Chemother       Date:  2012-02-23       Impact factor: 5.790

Review 2.  The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways.

Authors:  Ailie Marx; Akram Alian
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 3.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

Review 4.  The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication.

Authors:  Yi-Qun Kuang; Hong-Liang Liu; Yong-Tang Zheng
Journal:  Med Microbiol Immunol       Date:  2015-04-19       Impact factor: 3.402

5.  Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.

Authors:  Claudia Alteri; Matteo Surdo; Maria Concetta Bellocchi; Patrizia Saccomandi; Fabio Continenza; Daniele Armenia; Lucia Parrotta; Luca Carioti; Giosuè Costa; Slim Fourati; Fabiola Di Santo; Rossana Scutari; Silvia Barbaliscia; Valentina Fedele; Stefania Carta; Emanuela Balestra; Stefano Alcaro; Anne Genevieve Marcelin; Vincent Calvez; Francesca Ceccherini-Silberstein; Anna Artese; Carlo Federico Perno; Valentina Svicher
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

6.  Possible involvement of distinct phylogenetic clusters of HIV-1 variants in the discrepancies between coreceptor tropism predictions based on viral RNA and proviral DNA.

Authors:  Hiroshi Kotani; Koji Sudo; Naoki Hasegawa; Hiroshi Fujiwara; Tomohisa Hayakawa; Osamu Iketani; Masaya Yamaguchi; Mayumi Mochizuki; Satoshi Iwata; Shingo Kato
Journal:  J Pharm Health Care Sci       Date:  2016-11-09

Review 7.  Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.

Authors:  Carsten Münk; Björn-Erik O Jensen; Jörg Zielonka; Dieter Häussinger; Christel Kamp
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

Review 8.  Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV.

Authors:  Lutz G Gürtler; Josef Eberle
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.